2026-219 IP Notice Med 300 various

The New Hampshire Board of Medicine, operating through the Office of Professional Licensure and Certification (OPLC), issued a rulemaking notice (Notice 2026-219) proposing to repeal and readopt with amendment various sections of Med 300, which govern applications, qualifications, and examinations for initial physician licensure. The proposed changes implement legislative amendments to RSA 310 and RSA 329, including Laws of 2021, Chapter 197:78; Laws of 2023, Chapter 212:20; and Laws of 2024, Chapters 352 and 366, with the most recent statutory changes effective October 1, 2024 and July 1, 2026. Amended Med 301.03 introduces a universal application for initial licensure and an addendum. Under proposed Med 301.03(a)(2), applicants must disclose board certification status; attest to active engagement in clinical medicine within the past 12 months; disclose any failures, denials, or misconduct allegations in medical licensing examinations; and provide a yes or no answer to whether the DEA or any federal or state authority has taken action against, restricted, suspended, revoked, or investigated the applicant's controlled substance registration. Proposed Med 301.03(a)(3) requires applicants to complete a criminal history records check under RSA 329:11-a. The Board proposes to readopt Med 302.01 on educational requirements to align with RSA 329:12, I(a)(4)-(5) and Med 303.01 on examinations to align with RSA 329:12, I(a)(6). Med 303.02, governing candidates for USMLE Step 3, is proposed for outright repeal. Rules for locum tenens (Med 305.01), special camp and visiting professor (Med 305.02), administrative (Med 305.03), and resident training (Med 305.04) licenses are all proposed for readoption with amendment to incorporate the universal application and addendum. The fiscal impact statement notes that applicants for initial licensure may incur indeterminable costs to satisfy the active clinical practice attestation requirement in proposed Med 301.03(a)(2)(g). Applicable licensing and application processing fees are governed by Plc 1002.28. A public hearing is scheduled for December 2, 2026, and the written comment deadline is December 9, 2026.